z-logo
open-access-imgOpen Access
The application of the Chinese version of the Body Image Disturbance Questionnaire in patients with systemic lupus erythematosus
Author(s) -
Haoyang Chen,
Xin Chen,
Hongyan Yan,
Jebara Sofia Ben,
Xiaoyan Yao,
Pingyu Yang,
Minhua Zhang,
Tiantian Jin,
Biyu Shen
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024849
Subject(s) - cronbach's alpha , medicine , exploratory factor analysis , confirmatory factor analysis , reliability (semiconductor) , content validity , construct validity , validity , test (biology) , clinical psychology , psychometrics , structural equation modeling , statistics , paleontology , power (physics) , physics , mathematics , quantum mechanics , biology
This study aimed to translate the Body Image Disturbance Questionnaire (BIDQ) into Chinese and evaluate its reliability and validity in a sample of patients with systemic lupus erythematosus (SLE). Following the translation and revision of the Chinese version of the BIDQ, 169 patients with SLE were chosen as respondents to test the questionnaire's reliability and validity. We tested the content's validity through expert group evaluation. It is structural validity was examined through exploratory factor analysis and confirmatory factor analysis, and reliability was evaluated using Cronbach's α and test-retest reliability. The Chinese version of the BIDQ showed a content validity of .92. A two-factor structure was revealed by exploratory factor analysis, which explained 67.83% of the variance and proved by confirmatory factor analysis. Its overall Cronbach's α was .82 (P   <  .001), and the Cronbach's α for each item ranged from .76 to .83. The test-retest reliability was .82, with the Cronbach's α for each item ranging from .76 to .84. Thus, adequate reliability and validity of the Chinese version of the BIDQ were demonstrated for use in patients with SLE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here